Propan-2-yl 2-(1,4-dioxan-2-yl)acetate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二恶烷
• 英文名称: Propan-2-yl 2-(1,4-dioxan-2-yl)acetate
• 英文别名: propan-2-yl 2-(1,4-dioxan-2-yl)acetate
• 化学式: C₉H₁₆O₄
• 分子量: 188.22
• InChiKey: FTUIWQDOXIVRAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• CRYSTAL OF DPP-IV LONG-ACTING INHIBITOR AND SALT
  申请人：CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

  公开号：US20190284153A1

  公开（公告）日：2019-09-19

  The present application relates a crystal of a compound represented by Formula (I), a salt thereof, and a crystal of the salt thereof, a method for preparing the crystal of the compound represented by Formula (I), the salt thereof, and the crystal of the salt thereof, a crystal comprising the compound represented by Formula (I), a crystal composition comprising the crystal of the salt thereof, a pharmaceutical composition thereof, and medical uses thereof.

  本申请涉及一种由化学式（I）表示的化合物的晶体，其盐及其晶体，制备化学式（I）表示的化合物的晶体，其盐及其晶体的方法，包含化学式（I）表示的化合物的晶体，包含其盐晶体的晶体组合物，其药物组合物，以及其医药用途。
• CRYSTAL OF DPP-IV LONG-ACTING INHIBITOR AND SALT THEREOF
  申请人：Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

  公开号：EP3498704A1

  公开（公告）日：2019-06-19

  The present application relates a crystal of a compound represented by Formula (I), a salt thereof, and a crystal of the salt thereof, a method for preparing the crystal of the compound represented by Formula (I), the salt thereof, and the crystal of the salt thereof, a crystal comprising the compound represented by Formula (I), a crystal composition comprising the crystal of the salt thereof, a pharmaceutical composition thereof, and medical uses thereof.

  本申请涉及一种由式（I）代表的化合物、其盐和其盐的晶体，一种制备由式（I）代表的化合物、其盐和其盐的晶体的方法，一种包含由式（I）代表的化合物的晶体，一种包含由其盐的晶体的晶体组合物，一种其药物组合物及其医疗用途。
• Crystal of DPP-IV long-acting inhibitor and salt
  申请人：CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

  公开号：US10822319B2

  公开（公告）日：2020-11-03

  The present application relates to a crystal of a compound represented by Formula (I), a salt thereof, and a crystal of the salt thereof, a method for preparing the crystal of the compound represented by Formula (I), the salt thereof, and the crystal of the salt thereof, a crystal comprising the compound represented by Formula (I), a crystal composition comprising the crystal of the salt thereof, a pharmaceutical composition thereof, and medical uses thereof.

  本申请涉及一种由式（I）代表的化合物、其盐和其盐的晶体，一种制备由式（I）代表的化合物、其盐和其盐的晶体的方法，一种包含由式（I）代表的化合物的晶体，一种包含由其盐的晶体的晶体组合物，一种其药物组合物，以及其医疗用途。